Regular use of proton-pump inhibitors (PPIs) can increase the risk for hip fracture in postmenopausal women, especially those with a history of smoking, according to a study published recently in the British Medical Journal (BMJ). Key Point: Postmenopausal women who are regular users of PPIs have an increased risk of…
Read more »
indicates a Peer-Reviewed Article
Proton-pump inhibitors may be linked to increased risk of C. difficile-associated diarrhea
Proton-pump inhibitors (PPIs) may be associated with an increased risk of Clostridium difficile–associated diarrhea (CDAD). Doctors and patients are being warned that if a patient develops diarrhea that does not improve while receiving a PPI, then CDAD should be considered as a diagnosis and managed appropriately, according to an advisory…
Read more »